NCT05132946

Brief Summary

The study will include 40 patients who fulfil all the points in the inclusion and exclusion criteria will be randomized into two equal groups, each consisting of 20 patients, namely group (B) and group (C).

  • Group (B): will receive erector spinae plane block.
  • Group (C): will not receive any block. Postoperative pain score will be assessed using the FLACC scale or Face, Legs, Activity, Cry, Consolability scale immediately after extubation and at 1, 2, 4, 6, 8, 12, 18, and 24 hours. Routine postoperative analgesia in the form of intravenous paracetamol 7.5 mg/kg/6 hours will be given to all patients (the first dose is given after skin closure). Rescue analgesia in the form of 1 ug/kg fentanyl intravenously for patients if FLACC scale \> 4, and the time for the first rescue analgesic administration will be recorded.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 24, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2022

Completed
Last Updated

November 24, 2021

Status Verified

November 1, 2021

Enrollment Period

3 months

First QC Date

November 1, 2021

Last Update Submit

November 12, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The number of times for usage of fentanyl in postoperative period

    in the first 12 hours.

Study Arms (2)

Group (B): will receive erector spinae plane block.

ACTIVE COMPARATOR

unilateral ultrasound-guided erector spinae plane block using bupivacaine 0.25% (on the left side) with total volume 0.5 ml/kg and a maximum dose of 2 mg/kg of bupivacaine in erector spinae plane block group patients

Procedure: Nerve block

• Group (C): will not receive any block.

NO INTERVENTION

Interventions

Nerve blockPROCEDURE

unilateral ultrasound-guided erector spinae plane block using bupivacaine 0.25% (on the left side) with total volume 0.5 ml/kg and a maximum dose of 2 mg/kg of bupivacaine in erector spinae plane block group patients

Group (B): will receive erector spinae plane block.

Eligibility Criteria

Age3 Months - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All pediatric patients presented for aortic coarctation repair via left thoracotomy.

You may not qualify if:

  • Hypersensitivity to local anesthetic.
  • Mental or neurologic disorders.
  • Preoperative critically ill patients.
  • Parents or legal guardian refusal.
  • Infection at the site of injection.
  • Any liver disease.
  • Any coagulopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samar Soliman

Cairo, Nasr City, 11511, Egypt

RECRUITING

MeSH Terms

Interventions

Nerve Block

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaDenervationNeurosurgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Samar MD Soliman, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia

Study Record Dates

First Submitted

November 1, 2021

First Posted

November 24, 2021

Study Start

November 1, 2021

Primary Completion

February 1, 2022

Study Completion

February 10, 2022

Last Updated

November 24, 2021

Record last verified: 2021-11

Locations